Fragile X syndrome epidemiology and demographics: Difference between revisions
Line 6: | Line 6: | ||
== Overview == | == Overview == | ||
The prevalence of female carrier status has been estimated to be as high as 1 in 130-250 population; the prevalence of male carrier status is estimated to be 1 in 250-800 population. | |||
== Epidemiology and Demographics == | == Epidemiology and Demographics == |
Revision as of 20:02, 3 September 2021
Fragile X syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Fragile X syndrome epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Fragile X syndrome epidemiology and demographics |
Fragile X syndrome epidemiology and demographics in the news |
Risk calculators and risk factors for Fragile X syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The prevalence of female carrier status has been estimated to be as high as 1 in 130-250 population; the prevalence of male carrier status is estimated to be 1 in 250-800 population.
Epidemiology and Demographics
The fragile X syndrome has an estimated incidence of 1 in 3600 males and 1 in 4,000–6,000 females. [1] The prevalence of Fragile X syndrome is approximately 1 in 5000 men and 1 in 4000-6000 women worldwide, determined by molecular assays. [2] Fragile X Syndrome has been diagnosed in approximately 3 percent of boys with significant neurodevelopmental disorders. [3]
References
- ↑ Crawford, D.C.; Acuna, J.M. & Sherman, S.L. (2001) "FMR1 and the Fragile X syndrome: Human genome epidemiology review". Genet Med 3: 359-371
- ↑ Coffee B, Keith K, Albizua I, Malone T, Mowrey J, Sherman SL; et al. (2009). "Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA". Am J Hum Genet. 85 (4): 503–14. doi:10.1016/j.ajhg.2009.09.007. PMC 2756550. PMID 19804849.
- ↑ McConkie-Rosell A, Finucane B, Cronister A, Abrams L, Bennett RL, Pettersen BJ (2005). "Genetic counseling for fragile x syndrome: updated recommendations of the national society of genetic counselors". J Genet Couns. 14 (4): 249–70. doi:10.1007/s10897-005-4802-x. PMID 16047089.